Delivery Order SPE2DR25D3012-SPE2DR26F4C3M
Award Date 11/25/25
Potential Completion Date 12/17/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60 count) valued at $1,941.36 under a firm fixed price contract type. This award, issued on July 24, 2025, represents a non-competitive, non-set-aside transaction with an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for INBRIJA 42 mg inhalation capsules (60-count package) valued at $1,294.24 under a firm fixed price arrangement. The award, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $1,941.36 for INBRIJA 42 mg inhalation capsules (60-count) by the Defense Logistics Agency's Medical Supply Chain, a division of the Department of Defense. The contract, awarded on May 30, 2025, with an ultimate completion date of June 23, 2025, represents a firm fixed-price, competitively awarded procurement with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,132.50 to AmerisourceBergen Drug Corp for INBRIJA 42 mg inhalation capsules (60-count) on December 18, 2025, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of INBRIJA 42 mg inhalation capsules (60-count units) with a ceiling value of $1,941.36. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by May 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency has awarded a delivery order valued at $1,294.24 to AmerisourceBergen Drug Corp for INBRIJA 42 MG inhalation capsules (60-count), with an ultimate completion date of November 26, 2025. This non-set-aside competitive award was issued on November 4, 2025, under firm fixed pricing terms. The product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Inbrija 42 mg inhalation capsules (60-count package) under a firm fixed-price contract with a ceiling value of $1,879.50. This competitive award, with no set-aside designation, utilizes the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle valued through December 2026....
- This is a $1,294.24 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the drug INBRIJA 42 MG INHALATION CAP 60S, with a performance period through March 25, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a...
- This delivery order, valued at $3,882.72, awards AmerisourceBergen Drug Corp the supply of INBRIJA 42 MG inhalation capsules (60-count units) under a firm fixed price contract with the Defense Logistics Agency's Medical Supply Chain. The award was made on September 16, 2025, without a set-aside designation, indicating the contract was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency Troop Support Medical awarded a $1,251 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 60 capsules of the 42 mg dosage of INBRIJA, an inhalation medication used to treat Parkinson's disease symptoms. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 21, 2023 through August 11, 2023. No subcontractors or set aside designations...